Skip to menu Skip to content Skip to footer
Associate Professor David Wyld
Associate Professor

David Wyld

Email: 

Overview

Availability

Associate Professor David Wyld is:
Available for supervision

Works

Search Professor David Wyld’s works on UQ eSpace

214 works between 1998 and 2025

141 - 160 of 214 works

2016

Journal Article

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016)

Beesley, Vanessa L., Wockner, Leesa F., O'Rourke, Peter, Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David K. and Neale, Rachel E. (2016). Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016). Supportive Care in Cancer, 24 (8), 3601-3602. doi: 10.1007/s00520-016-3251-x

Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study (vol 24, pg 3589, 2016)

2016

Conference Publication

How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis

Wyld, D., Plage, S., Burge, M., Broom, A., Lwin, Z., McDade, H. and Cubitt, A. (2016). How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

How Long Is the Piece of String? - How Patients Negotiate the Uncertainties of a NET Diagnosis

2016

Conference Publication

Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate

Lucas, C., Goodman, S., Smith, J., Burge, M., Wyld, D. and Kumar, Ravi A. (2016). Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

Dosimetry to Estimate the Effect of Gelofusine (R) on the Renal Absorbed Dose of Lutetium 177-DOTA-Octreotate

2016

Conference Publication

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

Chan, B. A., Sim, H-W., Ravikumar, A., Bailey, D., Chan, D., Lawrence, B., McEwan, A., Pavlakis, N., Segelov, E., Singh, S., Roach, P. and Wyld, D. (2016). Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand). Oxford, United Kingdom: Oxford University Press.

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

2016

Conference Publication

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

Gunawan, Ben, Button, Elise, Bates, Tracey, Nasato, Gillian and Wyld, David (2016). Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

Unplanned admissions to a medical oncology unit at a tertiary hospital - an analysis of emergency presentations

2016

Conference Publication

Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy

Goodman, S., Smith, J., Kumar, Ravi A., Wyld, D. and Burge, M. (2016). Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

Pretherapy Identification of Patients at Risk of Receiving a High Renal Dose Undergoing Peptide Receptor Radionuclide Therapy

2016

Conference Publication

A systematic review and meta-analysis of patient reporting outcomes in clinical practice

Roberts, Natasha, Janda, Monika, Alexander, Kimberley and Wyld, David (2016). A systematic review and meta-analysis of patient reporting outcomes in clinical practice. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, Australia, 15–17 November 2016. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12635_4

A systematic review and meta-analysis of patient reporting outcomes in clinical practice

2016

Conference Publication

Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review

Kalas, Timothy S. and Wyld, David (2016). Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast International Hotel, Gold Coast, Queensland, Australia,, Gold Coast, QLD Australia. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

Optimizing adjuvant chemotherapy delivery in older women with breast cancer - a review

2016

Conference Publication

A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)

Ladwa, R., Burge, M. and Wyld, D. (2016). A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET). 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

A Single Centres Experience of Cardiac Metastasis from Neuroendocrine Tumours (NET)

2016

Conference Publication

A prospective 2-year experience of a medical oncology advanced trainee in Queensland

Ladwa, Rahul, Chern, Boris, Sanmugarajah, Jasotha and Wyld, David (2016). A prospective 2-year experience of a medical oncology advanced trainee in Queensland. COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing.

A prospective 2-year experience of a medical oncology advanced trainee in Queensland

2016

Journal Article

RAD51B in familial breast cancer

Pelttari, Liisa M., Khan, Sofia, Vuorela, Mikko, Kiiski, Johanna I., Vilske, Sara, Nevanlinna, Viivi, Ranta, Salla, Schleutker, Johanna, Winqvist, Robert, Kallioniemi, Anne, Dörk, Thilo, Bogdanova, Natalia V., Figueroa, Jonine, Pharoah, Paul D. P., Schmidt, Marjanka K., Dunning, Alison M., García-Closas, Montserrat, Bolla, Manjeet K., Dennis, Joe, Michailidou, Kyriaki, Wang, Qin, Hopper, John L., Southey, Melissa C., Rosenberg, Efraim H., Fasching, Peter A., Beckmann, Matthias W., Peto, Julian, Dos-Santos-silva, Isabel, Sawyer, Elinor J. ... Zeps, N. (2016). RAD51B in familial breast cancer. PLoS One, 11 (5) e0153788, e0153788. doi: 10.1371/journal.pone.0153788

RAD51B in familial breast cancer

2016

Journal Article

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

Schofield, Penelope E., Stockler, M. R., Zannino, D., Tebbutt, N. C., Price, T. J., Simes, R. J., Wong, N., Pavlakis, N., Ransom, D., Moylan, E., Underhill, C., Wyld, D., Burns, I., Ward, R., Wilcken, N. and Jefford, M. (2016). Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer. Supportive Care in Cancer, 24 (1), 401-408. doi: 10.1007/s00520-015-2792-8

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

2016

Conference Publication

The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression

Ladwa, R., Lyle, M., Wyld, D. and Burge, M. (2016). The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression. 13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona, Spain, Mar 09-11, 2016. Basel, Switzerland: S. Karger AG. doi: 10.1159/000448725

The Difficulties of Response Assessment after Peptide Receptor Radionucleotide Therapy (PRRT): An Unusual Case of Symptomatic Pseudoprogression

2016

Conference Publication

A single center experience of cardiac metastasis from neuroendocrine tumors (net)

Ladwa, Rahul, Burge, Matthew and Wyld, David (2016). A single center experience of cardiac metastasis from neuroendocrine tumors (net). COSA's 43 and ANZBCTG's 38 Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15-17 November 2016. Chichester, West Sussex United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12646

A single center experience of cardiac metastasis from neuroendocrine tumors (net)

2015

Journal Article

High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq

Kondrashova,Olga, Love, Clare J., Lunke, Sebastian, Hsu, Arthur L., Waring, Paul M., Taylor, Graham R., Australian Ovarian Cancer Study (AOCS) Group, Chenevix-Trench, G. and Wyld, D. (2015). High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq. PLoS One, 10 (11) e0143006, 1-14. doi: 10.1371/journal.pone.0143006

High-throughput amplicon-based copy number detection of 11 genes in formalin-fixed paraffin-embedded ovarian tumour samples by MLPA-seq

2015

Journal Article

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers

Burge, Matthew E., O'Rourke, Nick, Cavallucci, David, Bryant, Richard, Francesconi, Alessandra, Houston, Kathleen, Wyld, David, Eastgate, Melissa, Finch, Robert, Hopkins, George, Thomas, Paul and Macfarlane, David (2015). A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers. HPB, 17 (7), 624-631. doi: 10.1111/hpb.12418

A prospective study of the impact of fluorodeoxyglucose positron emission tomography with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers

2015

Journal Article

A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services

Beesley, Vanessa L., Janda, Monika, Goldstein, David, Gooden, Helen, Merrett, Neil D., O'Connell, Dianne L., Rowlands, Ingrid J., Wyld, David and Neale, Rachel E. (2015). A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services. Psycho-Oncology, 25 (2), 150-157. doi: 10.1002/pon.3887

A tsunami of unmet needs: pancreatic and ampullary cancer patients' supportive care needs and use of community and allied health services

2015

Conference Publication

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

Lawrence, Nicola, Toner, Guy, Martin, Andrew, Stockler, Martin, Yeung, Annie, Wong, Nicole, Thomson, Damien, Gebski, Val, Yip, Sonia, King, Madeleine, Friedlander, Michael, Quinn, David, Tan, Thean Hsiang, Chan, Howard, Hanning, Fritha, Weickhardt, Andrew, Jeffery, Mark, Stevanovic, Amanda, Hovey, Elizabeth, Wyld, David, Davis, Ian and Grimison, Peter (2015). A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302). COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours: the P3BEP Trial (Anzup 1302)

2015

Conference Publication

Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study

Jan, H., Wyld, D. and Burge, M. (2015). Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study. 12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Barcelona Spain, Mar 11-13, 2015. Basel, Switzerland: S. Karger AG. doi: 10.1159/000431385

Efficacy of PRRT in metastatic neuroendocrine tumors; a retrospective large single institutional study

2015

Conference Publication

Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer

Wyld, David, Gibson, Alexandra, Broom, Alex, Plage, Stefanie, Cubitt, Annette and Lwin, Zarnie (2015). Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer. COSA’s 42nd Annual Scientific Meeting. Rare Cancers, Hobart, TAS, Australia, 17-19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12432_2

Experiences of Uncertainty and Invisibility: Women's Accounts of Living with a Rare Cancer

Funding

Current funding

  • 2020 - 2026
    A new radio-imaging agent to guide targeted therapy for epithelial ovarian cancer
    NHMRC MRFF EPCDR - Ovarian Cancer Research
    Open grant

Past funding

  • 2020 - 2025
    PRoCESS: Pancreatic cancer Relatives Counselling and Education Support Service trial....(MRFF RCRDUN administered by QMIR)
    Queensland Institute of Medical Research
    Open grant

Supervision

Availability

Associate Professor David Wyld is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Associate Professor David Wyld's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au